Myeloma Minute: In search of myeloma precursors


| INNOVATION | Latest Research


New Myeloma Research Project Follows in the Footsteps of iStopMM to Study Myeloma Precursors

A new project will attempt to replicate iStopMM’s large, population-based approach—launched in Iceland in 2016—here in the U.S. Researchers hope to recruit approximately 50,000 individuals over the age of 45. The target population for the survey includes people with first-degree relatives who have had multiple myeloma, and African-Americans, since African-Americans are three times more likely than whites to develop the precursor conditions and tend to develop them at an earlier age.


| INSPIRATION | Myeloma Voices


| INSPIRATION | Donate a Photo


Myeloma Warrior Linda Sturm Remembers to Enjoy Every Moment of Life
One Week to Go: Donate Your Photo Now

Diagnosed on her 60th birthday, Linda Sturm has been living well with myeloma for 14 years with the support of the right team - her doctors, her husband, and the IMF. Listen to her share thoughts like, “When suddenly you have something wrong with you, and you get over the initial shock, you suddenly realize how precious life is … and you are not going to live forever … and you better take advantage of it and enjoy every moment of it.” Watch her story now.

Through the Donate-A-Photo campaign, you can donate one photo a day and Johnson & Johnson will donate $1 to the IMF through April 30, 2018! Download the Donate a Photo App, and snap your pic now to help fund research to cure myeloma. It really is that simple. It takes 25 photos to collect 100 blood samples for myeloma research. Donate your photo now!





Ask Dr. Durie: Doctors’ Edition Now Available for CME Credit

Now available from Medscape are CME courses for health-care professionals authored by the following myeloma experts: Drs. Brian G.M. Durie, Shaji Kumar, Thomas Martin, Joseph Mikhael, and Saad Usmani. This special edition of the “Ask Dr. Durie” series has been created for doctors and covers “Proteasome Inhibitors in Multiple Myeloma.” Participants must complete all sections of these activities to receive credit.


| Innovation | Drug Approval


Swedish Support Group Delighted by Approval of Darzalex (daratumumab) in Sweden

Darzalex® (daratumumab) has finally been approved for use in Sweden after two years of advocacy work by the Swedish support group Blodcancerförbundet, which is led by the President Lise-Lott Eriksson and IMWG member Dr. Hareth Nahi. This good news was the highlight of the second IMF Patient & Family Seminar held in Stockholm on April 21, 2018. At the seminar, a full house of participants enjoyed hearing about the next steps for potential treatments that would use daratumumab.


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



BOSTON Trial Fact Sheet

New isatuximab Clinical Trial: the IMROZ Study

New isatuximab Clinical Trial: the IKEMA Study

New ixazomib Clinical Trials: Learn How to Participate

Join the conversation about myeloma on the Smart Patients Message Board

April 28, 2018
Miles for Myeloma 5K Walk/Run
Philadelphia, PA

May 5-6, 2018
Miracles Happen When Pigs Fly!
Cincinnati, OH

May 12, 2018
IMF Regional Community Workshop
Seattle, WA

June 2, 2018
11th Annual Carolyn Czerkies Memorial Golf Outing
Joliet, IL


subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology
and individuals like you who supported the IMF this year

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.